clinical trial · NCT06873789
A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
Solid TumorsAdvanced Solid TumorsMetastatic Solid TumorsINCB177054Retifanlimab
brief summary
This study will be conducted to evaluate INCB177054 given as monotherapy or in combination with retifanlimab in participants with select advanced or metastatic solid Tumors.
started
Jun 30, 2025
primary completion
May 8, 2026
completion
May 8, 2026
last updated
Mar 25, 2026
official title
A Phase 1/2, Open-Label, Multicenter Study of INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol